Fortive Corp. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2025. Fortive Corporation operates in two strategic segments: Intelligent Operating Solutions (instrumentation, software, and services for industrial and safety applications) and Advanced Healthcare Solutions (workflow solutions for healthcare providers). A material event during the period was the separation of the former Precision Technologies segment into an independent publicly-traded company, Ralliant Corporation, on June 28, 2025. This business is now reported as a discontinued operation.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Sales (Continuing Ops) | $4,159.1 million | $4,080.9 million | +1.9% |
| Operating Profit | $720.2 million | $716.3 million | +0.5% |
| Operating Margin | 17.3% | 17.6% | -30 bps |
| Net Earnings (Continuing Ops) | $532.7 million | $482.5 million | +10.4% |
| Diluted EPS (Continuing Ops) | $1.59 | $1.37 | +16.1% |
| Operating Cash Flow | $1,035.7 million | $1,028.5 million | +0.7% |
| Long-Term Debt (Total) | $3.2 billion | $3.7 billion | Reduced |
| Cash and Equivalents | $375.5 million | $813.3 million | Reduced |
Material Changes vs. Prior Period
- Revenue Growth: Total sales grew 1.9% year-over-year, driven by favorable pricing of 2.2%, partially offset by a volume decline of 0.6%. Core revenue (excluding acquisitions and currency) grew 1.7%.
- Margin Compression: Operating profit margin decreased 30 basis points to 17.3%. This was primarily due to incremental stock-based compensation costs related to the Ralliant separation (-100 bps) and discrete restructuring charges (-55 bps), which offset benefits from pricing and productivity initiatives (+105 bps).
- Segment Performance:
- Intelligent Operating Solutions: Sales increased 2.3% to $2.86 billion; operating margin improved 50 bps to 25.8%.
- Advanced Healthcare Solutions: Sales increased 1.2% to $1.30 billion; operating margin decreased 20 bps to 10.6% due to modest volume declines in sterilization equipment.
- Capital Allocation: The company repurchased 30.4 million shares of common stock for approximately $1.61 billion. It also received a $1.15 billion dividend from Ralliant, which was used to fund share repurchases and repay approximately $716 million in debt (including Euro and Yen term loans and Euro notes).
- Discontinued Operations: Net earnings from discontinued operations were $46.5 million in 2025, compared to $350.4 million in 2024, reflecting the separation of the Precision Technologies segment.
Guidance, Outlook, and Risks
Outlook and Commentary: Management continues to deploy the "Fortive Accelerated" strategy, focusing on profitable organic growth, disciplined capital allocation, and investor trust. The company is actively managing tariff impacts through countermeasures and pricing actions. The effective tax rate for 2025 was 11.5%, significantly lower than the statutory rate due to foreign income taxed at different rates and foreign-derived intangible income deductions.
Key Risks and Contingencies:
- Geopolitical and Trade: Volatility in trade relations, tariffs, and the impact of the Supreme Court's IEEPA ruling on previously imposed tariffs create uncertainty regarding operational costs and supply chains.
- Separation Liabilities: Potential indemnification liabilities to Ralliant and Vontier Corporation pursuant to separation agreements could materially affect financial results.
- Regulatory Compliance: Extensive regulation in healthcare (FDA, HIPAA) and data privacy (GDPR, CCPA) poses compliance risks. The company also faces risks related to anti-bribery laws (FCPA) and export controls.
- Goodwill and Intangibles: As of December 31, 2025, goodwill and other intangible assets totaled approximately $9.5 billion. While no impairment was recorded in 2025, future negative economic trends could trigger impairment charges.
- Cybersecurity: The company faces ongoing risks from cyberattacks, data breaches, and the integration of AI into products and operations.
Investor Verification Checklist
- Verify the impact of the Ralliant separation on future revenue streams and the specific terms of indemnification liabilities retained.
- Monitor the effective tax rate sustainability, given the significant deviation from the statutory rate driven by foreign jurisdictions and specific tax credits.
- Assess the volume decline in the Intelligent Operating Solutions segment and its potential correlation with broader industrial cyclicality.
- Review the debt maturity schedule, noting the significant principal payments due in 2026 ($1.19 billion) and the company's ability to refinance or repay using operating cash flow.
- Track the execution of tariff countermeasures and their effectiveness in maintaining gross margins amidst global trade policy shifts.